BRAIN TUMOR, PRIMARY
Clinical trials for BRAIN TUMOR, PRIMARY explained in plain language.
Never miss a new study
Get alerted when new BRAIN TUMOR, PRIMARY trials appear
Sign up with your email to follow new studies for BRAIN TUMOR, PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Clearer brain scans: new agent shows promise for tumor detection
Diagnosis CompletedThis completed trial tested whether a new MRI contrast agent called Elucirem could produce clearer images of brain tumors compared to an existing agent called Dotarem. The study involved 138 adults with primary or recurrent brain gliomas who underwent specialized MRI scans. Resea…
Matched conditions: BRAIN TUMOR, PRIMARY
Phase: PHASE3 • Sponsor: Guerbet • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
New brain scan dye tested as safer alternative
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, which uses manganese instead of gadolinium, to see if it could safely and effectively detect lesions in the brain and central nervous system. It involved 18 adults with known conditions like brain tumors or multiple scler…
Matched conditions: BRAIN TUMOR, PRIMARY
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC
-
Surgeons use glowing dye to hunt brain tumors
Diagnosis CompletedThis study tested whether a safe, FDA-approved fluorescent dye called indocyanine green (ICG) could make brain tumors 'glow' under special near-infrared light during surgery. The goal was to help surgeons see the edges of the tumor more clearly so they could remove more of it, po…
Matched conditions: BRAIN TUMOR, PRIMARY
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Mar 27, 2026 12:39 UTC